AbbVie

handshake deal shake hand arrows ok yes

Biotech

AbbVie tosses ADARx $335M for siRNA options deal

The deal stretches across neuroscience, immunology and oncology and gives ADARx the chance to make “several billion dollars” in additional biobucks.

Zoey Becker May 14, 2025 9:00am

MA strategy deal block push come together form

M&A remains ‘top priority’ for pharmas in face of tariff threat

Apr 25, 2025 10:41am

Heidelberg Germany

German program matches lost NIH grants with pharma funders

Apr 7, 2025 10:50am

The Top Line

A closer look at pharma's top R&D budgets

Apr 4, 2025 9:34am

A representation of golden gas or oil pipes surrounded with coins on financial graph with candle bars

Top 10 pharma R&D budgets in 2024

Mar 31, 2025 6:00am

Manila folder with CONFIDENTIAL printed on it in red

AbbVie alleges Genmab 'willfully blind' to trade secret theft

Mar 24, 2025 5:51am